Key result
Neohesperidin significantly inhibited Angiotensin II-induced hypertension, vascular thickness, fibrosis, oxidative stress, and inflammation in vivo and in vitro.
Why the study?
Whether neohesperidin plays an important role in vascular endothelial injury induced by hypertension had not been clarified.
Does neohesperidin prevent Angiotensin II-induced hypertension and endothelial injury in mice?
Does neohesperidin prevent Angiotensin II-induced hypertension and endothelial injury in mice?
Neohesperidin attenuates Angiotensin II-induced hypertension and vascular endothelial injury in mice by reducing oxidative stress and inflammation.
Does not support clinical use; hypothesis-generating for neohesperidin in Ang II-mediated vascular disease.
Background: Currently, vascular endothelial damage caused by hypertension is one of the major health challenges facing countries around the world. Neohesperidin has been shown to play an important role in tumorigenesis and tumorigenesis, cardiac hypertrophy and remodeling, and oxidative stress. However, whether Nehesperidin plays an important role in endothelial injury induced by hypertension has not been clarified.Results: In this study, Angiotensin II was used to induce hypertension in mice. Blood pressure and vasoconstrictor function were measured, vascular thickness and fibrosis were detected by H&E and Masson tricolor staining, vascular inflammation was detected by immunofluorescence, oxidative stress was detected by DHE staining, and markers such as fibrosis, hypertrophy and oxidative stress were detected by qPCR. At the same time, we observed the effect of Nehesperidin on Ang II-induced HUVECs. The results showed that neohesperidin can significantly inhibit Ang II-induced hypertension, vascular thickness, fibrosis, oxidative stress and inflammation in vivo and in vitro. Conclusions: The results suggested that Nehesperidin could act as an antioxidant to significantly inhibit Ang II-induced hypertension and endothelial injury in HUVECs in mice by inhibiting oxidative stress response.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) studied Hypertension-induced endothelial injury. Neohesperidin vs. Angiotensin II alone was evaluated on Blood pressure and endothelial injury markers (p=<0.001). Neohesperidin significantly inhibited Angiotensin II-induced hypertension, vascular thickness, fibrosis, oxidative stress, and inflammation in vivo and in vitro.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: